QT Vascular

QT Vascular: Enrolled its first European patients in the ENDURE Trial in Germany. Multiple patients have already been enrolled in this study in New Zealand. The Study is a single-arm core-lab adjudicated multi-center clinical trial conducted to evaluate the efficacy of Chocolate Touch balloon cathether at intervals being 30 days, 3 months, 6 months and 12 months. The Chocolate Touch is a drug-coated peripheral balloon that combines the acute benefits of the Chocolate PTA Balloon Cathether with the potential long-term benefits of a paclitaxel-based coating, and was designed to provide uniform and less dilatation for patients with peripheral arterial disease. Another benefit of the Chocolate Touch relative to other drug coated balloons is that it does not require pre-treatment with another balloon, and has a larger contact surface for drug transfer. The product could provide an option for patients to leave the hospital without a permanent implant.